Baird Financial Group, Inc. Aveo Pharmaceuticals, Inc. Transaction History

Baird Financial Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$3.51 - $6.67 $201,063 - $382,077	-57,283 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$3.15 - $6.01 $16,235 - $30,975	5,154 Added 9.89%	57,283 $320,000
Q4 2021 Feb 09, 2022	SELL	$4.69 - $7.4 $23,454 - $37,007	-5,001 Reduced 8.75%	52,129 $244,000
Q3 2021 Nov 12, 2021	SELL	$5.12 - $6.89 $10,521 - $14,158	-2,055 Reduced 3.47%	57,130 $353,000
Q2 2021 Aug 11, 2021	BUY	$6.21 - $7.45 $35,726 - $42,859	5,753 Added 10.77%	59,185 $390,000
Q1 2021 May 13, 2021	BUY	$5.97 - $15.28 $318,989 - $816,440	53,432 New	53,432 $391,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.